Reviewed Consolidated Q1 31/03/2021 Qualified opinion with an emphasis of matters /Others 2020 Company Year 31/12/2020 Unqualified opinion with an emphasis of matters /Others 2020 Consolidated Year
Reviewed Consolidated Q1 31/03/2021 Qualified opinion with an emphasis of matters /Others 2020 Company Year 31/12/2020 Unqualified opinion with an emphasis of matters /Others 2020 Consolidated Year
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2021 Consolidated Year 31/12/2021 2021 Company Year 31/12/2021 2021 Reviewed Consolidated Q3 30/09
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2021 Consolidated Year 31/12/2021 2021 Company Year 31/12/2021 2021 Reviewed Consolidated Q3 30/09
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2021 Consolidated Year 31/12/2021 2021 Company Year 31/12/2021 2021 Reviewed Consolidated Q3 30/09
การเงิน 2022 Reviewed Company Q3 30/09/2022 2022 Reviewed Consolidated Q3 30/09/2022 2022 Reviewed Company Q2 30/06/2022 2022 Reviewed Consolidated Q2 30/06/2022 2022 Reviewed
งบการเงิน 2022 Reviewed Company Q3 30/09/2022 2022 Reviewed Consolidated Q3 30/09/2022 2022 Reviewed Company Q2 30/06/2022 2022 Reviewed Consolidated Q2 30/06/2022 2022 Reviewed
of the Company and the Company’s subsidiaries in the consolidated financial statements for the year ended 31 December 2017, compared to the same period of last year is as follows: Consolidated
the ended of 31st March 2018 as follows. The operation results of the Company and the Company’s subsidiaries in the consolidated financial statements for the period ended 31st March 2018, compared to
liquidity and to reduce the financial burden. The selling value is 40.48 % when compares to total assets from company consolidated statements. (Market Value 70,370,000.00 x 100 divided by total assets as at